Spontaneous Subarachnoid Hemorrhage
7
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Nursing Risk Management in Emergency SAH Surgery Using Healthcare Failure Mode and Effect Analysis(HFMEA)
Factors Influencing the Mortality of Patients With Subarachnoid Haemorrhage
Baricitinib for the Lung Injury Following Spontaneous SAH
Long-term Effects of Time to Treatment in Subarachnoid Haemorrhage
Time to Specialized Admission in Case of Severe Brain Haemorrhage.
A New Minimal-invasive Brain Tissue Probe Applying Near Infrared Spectroscopy
The Bilirubin Levels in Cerebrospinal Fluid of Spontaneous Subarachnoid Hemorrhage Patients